Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|February 2, 2021
ZIKA Virus Neutralizing Antibody Kinetics in Antenatally Exposed InfantsOtavio de Melo Espindola, Thomas Jaenisch, Karin Nielsen-Saines, et al.
International Journal of Psychology : Journal International De Psychologie|June 25, 2021
Measurement invariance of the Phubbing Scale across 20 countriesAgata Błachnio, Aneta Przepiórka, Oleg Gorbaniuk, et al.
Inflammatory Bowel Diseases|February 2, 2012
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of responseLior Katz, Javier P Gisbert, Beth Manoogian, et al.
Frontiers in Psychology|January 10, 2022
Country Indicators Moderating the Relationship Between Phubbing and Psychological Distress: A Study in 20 CountriesAgata Błachnio, Aneta Przepiórka, Oleg Gorbaniuk, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEWNathaniel A Cohen, Neta Sror, Maliha Naseer, et al.
BMC Medical Research Methodology|May 25, 2023
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)Joyce W Y Mak, Yang Sun, Julajak Limsrivilai, et al.
Gastroenterology|June 1, 2023
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree RelativesJuan Antonio Raygoza Garay, Williams Turpin, Sun-Ho Lee, et al.
International Journal of Psychology : Journal International De Psychologie|August 13, 2024
Measurement invariance of the Facebook intrusion questionnaire across 25 countriesAgata Błachnio, Aneta Przepiórka, Oleg Gorbaniuk, et al.
Cancer Discovery|December 6, 2024
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12CAnna E Maciag, James P Stice, Bin Wang, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.
Pageof 17